Видео ютуба по тегу Faron Pharmaceuticals

Petri Bono, Chief Medical Officer Faron Pharmaceuticals
Petri Bono, Chief Medical Officer Faron Pharmaceuticals
Генеральный директор Faron Pharmaceuticals о воодушевляющих результатах испытаний и планах на буд...
Генеральный директор Faron Pharmaceuticals о воодушевляющих результатах испытаний и планах на буд...
Reprogramming macrophages for therapeutic benefit
Reprogramming macrophages for therapeutic benefit
Faron Pharmaceuticals: FDA Approval next steps for orphan drug status
Faron Pharmaceuticals: FDA Approval next steps for orphan drug status
Faron's promising phase II BEXMAB trial data
Faron's promising phase II BEXMAB trial data
Faron Pharmaceuticals: Clever-1 Biomarker targeting cancer's core for better results
Faron Pharmaceuticals: Clever-1 Biomarker targeting cancer's core for better results
Faron Pharmaceuticals Executives on Cell Therapy Technologies | VibeCast Episode 29
Faron Pharmaceuticals Executives on Cell Therapy Technologies | VibeCast Episode 29
Miljardimenestyksen kynnyksellä, Faronin Juho Jalkanen?
Miljardimenestyksen kynnyksellä, Faronin Juho Jalkanen?
Faron H1'25: Kohti ratkaisevaa tutkimusta
Faron H1'25: Kohti ratkaisevaa tutkimusta
Faronin rahoitusratkaisu: Selkänoja seuraaviin askeliin
Faronin rahoitusratkaisu: Selkänoja seuraaviin askeliin
Faron Pharmaceuticals Ltd
Faron Pharmaceuticals Ltd
Faron Pharmaceuticals' present 'groundbreaking' results from Bexmarilimab cancer treatment trial
Faron Pharmaceuticals' present 'groundbreaking' results from Bexmarilimab cancer treatment trial
Faron Pharmaceuticals sijoituskohteena | Pörssisijoittajan viikko 13.9.2022
Faron Pharmaceuticals sijoituskohteena | Pörssisijoittajan viikko 13.9.2022
Faron Pharmaceuticals outlines groundbreaking work in cancer treatment - presentation
Faron Pharmaceuticals outlines groundbreaking work in cancer treatment - presentation
Faron: Tutkimustulokset tukevat siirtymistä ratkaisevaan vaiheeseen
Faron: Tutkimustulokset tukevat siirtymistä ratkaisevaan vaiheeseen
Dr. Juho Jalkanen - CEO, Faron Pharmaceuticals - Tackling Cancers Via Novel Immunotherapies
Dr. Juho Jalkanen - CEO, Faron Pharmaceuticals - Tackling Cancers Via Novel Immunotherapies
Ilika, Faron Pharmaceuticals, Hercules, Genflow Biosciences, Frontier IP Group, Bluefield Solar
Ilika, Faron Pharmaceuticals, Hercules, Genflow Biosciences, Frontier IP Group, Bluefield Solar
Faron:
Faron: "Kassa ei lopu kesken!"
Faron Pharmaceuticals CEO on benefits of Innovation Passport for cancer immunotherapy
Faron Pharmaceuticals CEO on benefits of Innovation Passport for cancer immunotherapy
Faron Pharmaceuticals drug has 'tremendous potential' following Korea deal, says CEO
Faron Pharmaceuticals drug has 'tremendous potential' following Korea deal, says CEO
Faron Pharmaceuticals' Markku Jalkanen presents at the Biotech Capital Conference
Faron Pharmaceuticals' Markku Jalkanen presents at the Biotech Capital Conference
Ep. 86 – Macrophages, ASCO & Clever-1: Faron CEO Juho Jalkanen on Bexmarilimab’s Promise
Ep. 86 – Macrophages, ASCO & Clever-1: Faron CEO Juho Jalkanen on Bexmarilimab’s Promise